U.S. Supreme Court Rejects Abortion Pill Challenge on Standing
- June 14, 2024
A unanimous U.S. Supreme Court rejected June 13 an action that sought to significantly curtail access to the abortion pill mifepristone, holding the plaintiffs lacked standing to challenge the Food and Drug Administration’s (FDA’s) regulatory regime for the drug.
ARTICLE TAGS
You must be logged in to access this content.